Background. OXA-48 is a highly prevalent carbapenemase and has been isolated worldwide. Here, we investigate the in vivo horizontal gene transfer (HGT) of bla OXA−48 from Klebsiella pneumoniae to Escherichia coli in an infected patient.
from North Africa, Europe, and Asia [6] . It was just a matter of time until OXA-48 would also arrive in the United States, where it was finally discovered in early 2013 [7, 8] . Today, OXA-48 is one of the most prevalent carbapenemases worldwide [2, 6, 9] . The global dissemination of OXA-48-producing multidrugresistant, gram-negative rods and the presence on mobile genetic elements in a broad range of species have established OXA-48 as a major public health threat in recent years.
Plasmid-borne OXA-48 is mainly present in K. pneumoniae and represents a major risk for hospitalized patients. However, spread of these resistance plasmids into Escherichia coli, the most abundant facultative anaerobic colonizer of the human intestinal tract, poses an ever greater public health threat: Multiresistant E. coli strains may become part of the physiological human intestinal microbiota and, thereby, become a notable source of infections among sick and healthy persons in healthcare settings and the community [10] . Understanding these dissemination mechanisms will be essential for the development of durable infection control measures [11] .
In the present study, we describe a nosocomial outbreak of a carbapenem-resistant K. pneumoniae clone expressing bla OXA-48 . We provide evidence for the transmission of OXA-48 from K. pneumoniae to E. coli in an infected patient and investigate the intergenus horizontal gene transfer (HGT) in vitro and in vivo, thereby presenting a novel in vivo model for the investigation of resistance plasmid transmission.
MATERIALS AND METHODS

Bacterial Isolates
Ertapenem-resistant K. pneumoniae clinical isolates KP1-KP6 were obtained from 6 patients who were admitted to the Department of Internal Medicine, Hospital of Johann Wolfgang Goethe University Frankfurt in Germany, from April to July 2010. In addition, a carbapenem-susceptible E. coli (ECS) isolate and a carbapenem-resistant E. coli (EC1) isolate could be recovered from rectal swabs from 1 patient on day 62 and day 105, respectively, of his hospital stay. Experimental procedures for antimicrobial susceptibility testing, detection of carbapenemases, and multilocus sequence typing (MLST) are presented in the Supplementary Data.
Analysis of Clonality Using the DiversiLab System
Genetic similarity was investigated by semiautomated repetitive sequence-based polymerase chain reaction (rep-PCR) using the DiversiLab strain typing platform (bioMérieux, Nürtingen, Germany). Results were utilized using the DiversiLab software employing Pearson correlation to determine distance matrices and the unweighted pair group method with arithmetic averages to create dendrograms [12] . Isolates that clustered >95% were considered related.
In Vitro Liquid Mating Experiments
HGT of the plasmid harboring bla OXA-48 (pOXA-48) in vitro was evaluated by transconjugation assays using 1 × 10 9 colony-forming units (CFU) of KP1 as a donor and 1 × 10 9 CFU of the sodium azide-resistant strain E. coli J53 as a recipient in a volume of 1 mL lysogeny broth (LB) medium. Transconjugants were selected using chromogenic coliform agar (Carl Roth, Karlsruhe, Germany) plates containing sodium azide and ampicillin (each 100 µg/mL). Transconjugation frequency was determined by dividing the numbers of transconjugants by the number of donors. Molecular characterization of pOXA-48 is described in the Supplementary Data. To investigate the influence of motility and fitness on HGT of pOXA-48, E. coli isolate RuSR was employed as the recipient, which displayed a slow-growing, motile-deficient phenotype as determined by growth kinetics in LB medium (Supplementary Figure 2 ) and the hanging drop method, respectively.
In Vivo Transconjugation of pOXA-48 in Galleria mellonella
The invertebrate infection model Galleria mellonella was used to study HGT of pOXA-48 from K. pneumoniae to E. coli. Larvae of the greater wax moth (G. mellonella) in the final instar larval stage were injected with a phosphate-buffered saline solution containing 10 6 CFU of K. pneumoniae and E. coli into the last left and last right proleg, respectively, using a Hamilton precision syringe. After incubation at 37°C for 24 hours in the dark in petri dishes, larvae were mechanically homogenized and 100 µL of the homogenate was spread on chromogenic coliform agar plates containing 100 µg/mL of ampicillin, sodium azide, or both. After 24 hours, colonies were enumerated and transconjugation frequencies calculated.
In Vivo Transconjugation of pOXA-48 in Mice
To investigate HGT of pOXA-48 in mammals, gnotobiotic mice (C57BL/6J background) colonized with a low-complexity microbiota (LCM) were used [13] [14] [15] . These mice are associated with members of the Altered Schaedler flora [13] and were kept in individually ventilated cages at the Rodent Center (Hönggerberg Chemistry Building), Eidgenössische Technische Hochschule Zürich, Switzerland. The microbiota of LCM mice is devoid of Enterobacteriaceae, which was routinely confirmed by culture. For analysis of HGT, LCM mice were infected by oral gavage with a total of 5 × 10 7 CFU of mixtures of bla OXA-48 harboring K. pneumoniae and E. coli J53 as described previously [14] . Vital bacterial loads in the feces and cecal contents were determined on days 1-3 post infection by plating on chromogenic coliform agar containing the respective antibiotics (ampicillin and/or sodium azide).
RESULTS
Outbreak With Carbapenem-Resistant Klebsiella pneumoniae
In April to July 2010, a total of 6 patients were identified to be colonized or infected with carbapenem-resistant K. pneumoniae (isolates KP1-KP6). These patients were hospitalized on the same ward at the Department of Internal Medicine of the Hospital of Johann Wolfgang Goethe University in Frankfurt, Germany. All case patients were suffering from severe kidney disease, and 4 of them were kidney transplant recipients. Patient characteristics are shown in Table 1 . KP1 was isolated from a rectal swab from patient 1 during routine screening on day 14 of his hospital stay ( Figure 1 ). On day 105, a carbapenem-resistant E. coli was isolated from a rectal swab from patient 1 (Figure 1 ). Susceptibility testing of isolates KP1-KP6 and EC1 revealed nonsusceptibility to β-lactam antibiotics, fluoroquinolones, and cotrimoxazole ( Table 2 and Supplementary Table 1 ). All isolates remained susceptible to gentamicin, amikacin, tigecycline, and colistin.
Detection and Characterization of bla Oxa-48
Screening for ESBL and carbapenemase genes by PCR and subsequent sequencing revealed the presence of the bla gene OXA-48 and the broad-spectrum lactamases bla CTX-M-15 , bla TEM-1 , bla OXA-1 , and bla SHV-1 in KP1-KP6. EC1 tested positive for bla OXA-48 , bla CTX-M-1 , and bla TEM-1 . Primer walking of 5. Figure 2) . MLST of KP1-KP6 revealed the sequence type (ST) 14, which has been associated with OXA-48 in the United Kingdom [1] . Analysis of genetic relatedness between all K. pneumoniae isolates KP1-KP6 using semiautomated rep-PCR revealed a similarity of >96%, suggesting clonality of these isolates and thus confirming an outbreak with OXA-48-harboring K. pneumoniae ( Figure 2A ).
Intergenus Horizontal Gene Transfer of bla Oxa-48 From K. pneumoniae to E. coli
In addition to KP1 and EC1, which were recovered from rectal swabs from patient 1, an ESBL-producing, carbapenem-susceptible E. coli had been isolated from this patient from a rectal swab on day 62 ( Figure 1 ). MLST analysis of both EC1 and ECS revealed a novel combination of alleles and thus an asyet undescribed ST that was designated ST666. Furthermore, the 2 E. coli isolates from patient 1, EC1 and ECS, both expressed bla CTX-M-1 and bla TEM-1 and showed a genetic similarity of >97%, likewise indicating clonality ( Figure 2B ). These data suggest that an intergenus HGT of bla OXA-48 from KP1 to the ESBL-producing ECS in patient 1 had occurred, giving rise to the OXA-48-harboring, ESBL-producing E. coli EC1.
Horizontal Gene Transfer of bla Oxa-48 In Vitro
To investigate genetic localization and transferability of bla OXA-48 , in vitro transconjugation assays using KP1 as a donor and the sodium azide-resistant E. coli J53 as a recipient were performed. OXA-48 was successfully transferred to E. coli J53, suggesting its location on a plasmid. The conjugation frequency of pOXA-48 from KP1 to E. coli J53 was determined to be 8.7 × 10 −7 under standard laboratory conditions ( Figure 3A) . Plasmid typing and PFGE of the bla OXA-48 -carrying plasmid ( pOXA-48) revealed a plasmid of approximately 60 kb in size with an IncL/M-like backbone, which was present in both the OXA-48 transconjugants and the clinical K. pneumoniae isolates (data not shown). Escherichia coli J53 transconjugants expressing OXA-48 were resistant to penicillins, ertapenem, and imipenem, but remained susceptible to second-and third-generation cephalosporins (Table 2) . Transconjugants exhibited elevated minimum inhibitory concentrations (MICs) toward meropenem and doripenem with 0.5 mg/L and 0.25 mg/L, respectively, but still remained in the susceptible range. The OXA-48-carrying transconjugants did not show any resistance to non-β-lactam antibiotics, suggesting that no other resistance genes were located on the plasmid.
Horizontal Gene Transfer of bla Oxa-48 In Vivo
To investigate the intergenus HGT in more detail and to mimic the in vivo situation that has presumably occurred in the patient, we established an in vivo conjugation system. For this, larvae of the G. mellonella were employed, as G. mellonella has become a well-established model organism for studying virulence and in vivo evaluation of antibiotic efficacy [17] [18] [19] . Larvae were injected with a mixture of 1 × 10 6 CFU of OXA-48 harboring KP1 as a donor and E. coli J53 as a recipient. After 24 hours, larvae were mechanically disrupted and spread on agar plates containing ampicillin and sodium azide to select for OXA-48-harboring E. coli J53 transconjugants. Here, a >100-fold higher conjugation frequency of 1.3 × 10 −4 was calculated compared to the in vitro experiments ( Figure 3A ; P < .01).
To get further information on the efficiency of bacterial intergenus plasmid transfer in the mammalian intestine and to better mimic the in vivo situation, we used a gnotobiotic mouse model, based on an LCM, which had been previously established for this purpose [14] . LCM mice are associated with members of the Altered Schaedler flora and lack any members of the Enterobacteriaceae family that could interfere with the infection experiments. Colonization resistance against bacterial pathogens (eg, Salmonella enterica, E. coli) is drastically reduced in LCM mice [14] . As a consequence, they are susceptible to high-level colonization (10 8 -10 10 CFU/g intestinal content) of the lower gut by E. coli and relatives. LCM mice were coinfected with KP1 and E. coli J53 by oral gavage. After 24 hours, fecal samples were collected and live bacterial loads were determined by plating on the respective selective plates. As anticipated, total loads of the donor and recipient strain were high (1.5 × 10 8 ± 5.8 × 10 7 and 1.3 × 10 8 ± 4.7 × 10 7 , respectively). The conjugation frequency was determined to be 2.9 × 10 −5 and was thus approximately 30-fold higher than under in vitro conditions ( Figure 3A ; P < .05). Furthermore, total numbers of OXA-48-carrying E. coli transconjugants were steadily rising from day 1-3 ( Figure 3B ), whereas CFU of donors and acceptors were not ( Figure 3C ). This shows that the OXA-48-containing plasmid was indeed efficiently transferred from the clinical K. pneumoniae isolate to E. coli in the gut of gnotobiotic mice as it has presumably occurred in the hospital setting in the intestine of patient number 1. Finally, we evaluated the influence of fitness and motility on transconjugation efficiency of pOXA-48. Therefore, HGT of pOXA-48 from KP1 to the slow-growing, motile-deficient E. coli isolate RuSR was analyzed in vitro and in vivo. Strikingly, whereas a transconjugation frequency of 6.0 × 10 −7 was determined in liquid mating assays (n = 3), no transconjugants were observed in vivo using Galleria wax moth larvae (n = 3) and LCM mice (n = 5). This indicates that essential capabilities such as motility and fitness are necessary for HGT in the in vivo models but not in vitro.
DISCUSSION
In this study, we describe an outbreak with OXA-48-producing carbapenem-resistant K. pneumoniae belonging to ST14, which has disseminated worldwide but has rarely been linked to OXA-48, as has ST395 or ST11. MLST analysis of E. coli isolates EC1 and ECS from the index patient revealed an as-yet undescribed ST, which was designated ST666. The closest related STs are ST131 and ST156. Notably, ST131 is the major successful and multidrug-resistant E. coli clone worldwide, whereas ST156 has been associated with a virulent phenotype causing sepsis in neonates and ESBL production [20, 21] .
In our study, all infected patients survived by receiving a combination therapy of meropenem and gentamicin and, in case of pneumonia, with inhaled colistin in addition. This suggests that infections with OXA-48-positive Enterobacteriaceae can be successfully treated with a carbapenem in combination with an aminoglycoside if the carbapenem MIC is ≤8 mg/L. Indeed, several studies recommend a combination regimen containing a carbapenem if a MIC of ≤4-8 mg/L is recorded, as this has resulted in an improved outcome [22] [23] [24] [25] [26] .
After initial isolation of bla OXA-48 -carrying K. pneumoniae (KP1), a bla OXA-48 -harboring E. coli (EC1) was recovered in addition from rectal swabs of the index patient. Several facts indicate that an intergenus HGT of pOXA-48 from K. pneumoniae to E. coli occurred, most likely in the intestine of the index patient: (1) an ESBL-producing, OXA-48-negative E. coli (ECS) clonal to EC1 was isolated prior to the emergence of EC1; (2) the genetic environment of bla OXA-48 in EC1 and KP1 was identical; and (3) the size of approximately 60 kb of pOXA-48 from EC1 was identical to that of KP1-KP6. Notably, the index patient was treated with amoxicillin and metronidazole at the beginning of his hospital stay. This most likely reduced numbers of the obligate anaerobic intestinal microbiota and, at the same time, favored outgrowth of KP1 donor and ECS acceptor strains, which facilitated HGT of pOXA-48.
Molecular epidemiology of OXA-48-producing K. pneumoniae has been analyzed in detail in several studies [1] [2] [3] [4] [5] [6] [7] [8] , but little is known about the in vivo transmission of OXA-48 via HGT. We therefore established a new in vivo conjugation model employing the larva of the greater wax moth (G. mellonella), which has been widely used to study bacterial virulence [ [17] [18] [19] . In this model system, interaction with the innate immune system of Galleria as well as motility and fitness of bacterial strains influence their survival in a hostile environment. Therefore, this model may mimic more closely the situation in humans than conventional but highly artificial in vitro transconjugation assays. To further evaluate the results of the Galleria model, a mammalian model system was employed. Therefore, HGT efficiency of pOXA-48 was analyzed by intragastral infection of gnotobiotic mice, colonized with a defined and LCM. LCM mice are characterized by the absence of gram-negative bacteria in their gut microbiota. By enumeration of donors and transconjugants in the feces of the mice, we were able to monitor the continuous increase in intestinal transconjugant density ( Figure 3B ). The emergence of transconjugants is affected by 2 major phenomena: efficacy of the transconjugation process itself and by plasmid-encoded fitness factors favoring transconjugant growth [14] . As no growth advantage of OXA-48-carrying E. coli J53 transconjugants has been observed compared to the parental strain in in vitro growth kinetics (Supplementary Figure 3) , HGT of bla OXA-48 seemed to have taken ). Hence, it is tempting to speculate that HGT of carbapenemase genes might occur more frequently in vivo than previously estimated by in vitro experiments. Notably, when using a slow-growing, motile-deficient acceptor, we observed that the essential capabilities of motility and fitness were necessary for efficient HGT among in vivo models but not in vitro. Thus, the herein-described in vivo models might help to investigate the dissemination of clinically relevant antibiotic resistance genes under more realistic conditions than those currently used within in vitro models. This is crucial to develop innovative strategies to curtail the spreading of carbapenemase-encoding plasmids in the future.
Supplementary Data
Supplementary materials are available at Clinical Infectious Diseases online (http://cid.oxfordjournals.org). Supplementary materials consist of data provided by the author that are published to benefit the reader. The posted materials are not copyedited. The contents of all supplementary data are the sole responsibility of the authors. Questions or messages regarding errors should be addressed to the author. Figure 3 . A, Transconjugation frequencies during horizontal gene transfer of plasmid harboring bla OXA-48 ( pOXA-48) from Klebsiella pneumoniae (KP) clinical isolate KP1 to Escherichia coli J53 in vitro (n = 15) and in vivo using Galleria mellonella (n = 7) and low-complexity microbiota (LCM) C57 BL/6 mice (n = 5), respectively, as hosts. The asterisks indicate significant differences as determined by the 2-tailed Student t test (*P < .05, **P < .01). Colonization levels of OXA-48 carrying E. coli J53 transconjugants (B) and OXA-48 carrying KP1 donors and E. coli J53 acceptors (C) in the gut of LCM mice at days 1, 2, and 3 postinoculation. Colony-forming units (CFUs) were determined by plating feces on chromogenic media containing 100 µg/mL each of ampicillin, sodium azide, or both. Bars represent the mean.
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